21
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Ulcerative Colitis with Olsalazine and Sulphasalazine: Efficacy and Side-Effects

, &
Pages 70-75 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

C. Scheurlen, S. Wedel, W. Kruis, F. M. Zwiebel, H. Allgayer & R. Scholz. (1992) Olsalazine-Related Diarrhoea: Does Rat Intestine Adapt in Vivo?. Scandinavian Journal of Gastroenterology 27:4, pages 311-316.
Read now

Articles from other publishers (19)

Alistair Murray, Tran M Nguyen, Claire E Parker, Brian G Feagan & John K MacDonald. (2020) Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Yongjun Wang, Claire E Parker, Tania Bhanji, Brian G Feagan & John K MacDonald. (2016) Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews.
Crossref
Atsushi Sakuraba. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 55 68 .
Brian G Feagan & John K MacDonald. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lloyd R Sutherland & John K MacDonald. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Altamash I. Qureshi & Russell D. Cohen. (2005) Mesalamine delivery systems: do they really make much difference?. Advanced Drug Delivery Reviews 57:2, pages 281-302.
Crossref
William J. Sandborn. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 605 629 .
E. V. LoftusJRJR, S. V. Kane & D. Bjorkman. (2004) Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Alimentary Pharmacology & Therapeutics 19:2, pages 179-189.
Crossref
L Sutherland & JK MacDonald. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
William J. Sandborn. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 605 629 .
Russell D Cohen, Douglas M Woseth, Ronald A Thisted & Stephen B Hanauer. (2000) A Meta-Analysis and Overview of The Literature on Treatment Options for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. American Journal of Gastroenterology 95:5, pages 1263-1276.
Crossref
Kruis, Brandes, Schreiber, Theuer, Krakamp, Schütz, Otto, Lorenz-Mayer, Ewe & Judmaier. (1998) Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis. Alimentary Pharmacology & Therapeutics 12:8, pages 707-715.
Crossref
Lloyd R. Sutherland, Daniel E. Roth & Paul L. Beck. (1997) Alternatives to Sulfasalazine: A Meta-analysis of 5-ASA in the Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases 3:2, pages 65-78.
Crossref
S.P.L. Travis & D.P. Jewell. (1994) Salicylates for inflammatory bowel disease. Baillière's Clinical Gastroenterology 8:2, pages 203-231.
Crossref
M. A. Peppercorn. (1993) A critical evaluation of the therapeutic benefits and side-effects of aminosalicylate analogues in the treatment of inflammatory bowel disease. InflammoPharmacology 2:3, pages 263-276.
Crossref
B Crotty & DP Jewell. (2012) Drug therapy of ulcerative colitis.. British Journal of Clinical Pharmacology 34:3, pages 189-198.
Crossref
H. Allgayer, P. Höfer, M. Schmidt, P. Böhne, W. Kruis & R. Gugler. (1992) Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Biochemical Pharmacology 43:2, pages 259-262.
Crossref
V. Diehl, M. Schumacher, H.-L. Schreiber, J. Schuster, D. Hoelzer, W. Kruis, W. Rafflenbeul & M. Buyse. 1991. Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 491 509 .
K. Ewe. 1988. 94. Kongreß. 94. Kongreß 178 184 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.